Unique ID issued by UMIN | UMIN000033810 |
---|---|
Receipt number | R000038568 |
Scientific Title | Study of the effects of the food containing plant-derived ingredient on brain function and sleep |
Date of disclosure of the study information | 2018/08/21 |
Last modified on | 2021/01/08 23:23:03 |
Study of the effects of the food containing plant-derived ingredient on brain function and sleep
Effects of plant-derived ingredient on brain function and sleep
Study of the effects of the food containing plant-derived ingredient on brain function and sleep
Effects of plant-derived ingredient on brain function and sleep
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To confirm the effects of plant-derived ingredient on brain function and sleep
Efficacy
Evaluation of the brain function (cognitrax) and sleep quality (OSA Questionnaire, St. Mary's Hospital Sleep Questionnaire, sleep efficiency and nocturnal awakening time assessed by actigraph) before and after the 2-week treatment period.
Symptoms questionnaires, medical interview by physician, anthropometric measurements
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
No need to know
2
Prevention
Food |
Intake of active beverage (containing plant-derived ingredient) once a day for 2 weeks -> washout (2 weeks) -> Intake of placebo beverage (not containing plant-derived ingredient) once a day for 2 weeks.
Intake of placebo beverage (not containing plant-derived ingredient) once a day for 2 weeks -> washout (2 weeks) -> Intake of active beverage (containing plant-derived ingredient) once a day for 2 weeks.
50 | years-old | <= |
65 | years-old | >= |
Male and Female
-healthy adult aged from 50 to 65
-Subjects who feeling sleep, or associated lowing function of their brain
-Subjects who sleep more than five hours usually
-Subjects who is not with disorders about sleep
-Healthy subjects with not serious disorders
-Subjects not difficult to deal with PC
-Subjects with normal color sensation
-Subjects who have food allergy
-Subjects who have metal allergy
-Subjects who take a psychotropic medicine
-Subjects who take a health food
-non-smoking
-Inadequate with physician's decision
26
1st name | Ono |
Middle name | |
Last name | Takahiro |
Ueno-Asagao Clinic
Head
110-0015
Kairaku Building 6F, 2-7-5, Higashiueno, Taito-ku, Tokyo, 110-0015, JAPAN
03-6240-1162
t.ono@ueno-asagao.clinic
1st name | Ryoma |
Middle name | |
Last name | Shimizu |
TES Holdings Co., Ltd.
Administrative Department of Clinical Trials
110-0015
Kairaku Building 6F, 2-7-5, Higashiueno, Taito-ku, Tokyo, 110-0015, JAPAN
03-6801-8480
r.shimizu@tes-h.co.jp
TES Holdings Corporation
Kao Corporation
Profit organization
The Ethics Committee of the Oriental Ueno Detection Center, General Incorporated Association Oriental Occupational Health Association Tokyo Branch
Ueno Taito-ku Tokyo 110-0005, JAPAN
03-5816-0711
i.takahashi@tes-h.co.jp
NO
うえのあさがおクリニック(東京都)
2018 | Year | 08 | Month | 21 | Day |
Unpublished due to the protocol including the intellectual property rights
Unpublished
works in progress
26
A significant difference was observed in the primary outcome
2021 | Year | 01 | Month | 08 | Day |
Healthy adults
25 participants completed and 25 subjects were incorporated into the analyses
No adverse effect reported
Cognitive function
Completed
2018 | Year | 07 | Month | 30 | Day |
2018 | Year | 07 | Month | 30 | Day |
2018 | Year | 09 | Month | 01 | Day |
2018 | Year | 12 | Month | 01 | Day |
2019 | Year | 01 | Month | 28 | Day |
2019 | Year | 02 | Month | 18 | Day |
2019 | Year | 03 | Month | 19 | Day |
2018 | Year | 08 | Month | 20 | Day |
2021 | Year | 01 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038568